Skip to main content
Earnings Labs
NewAmsterdam Pharma Company N.V. logo

NewAmsterdam Pharma Company N.V. (NAMS) Earnings

NASDAQ·Healthcare·Biotechnology

$30.55

+0.94%

Mkt Cap $3.54B

EPS — Estimate vs Actual

Mkt Cap

$3.54B

P/E

Fwd P/E

P/S

156.77

Rev TTM

EPS TTM

-$1.81